First human test for new eye drop formula begins
NCT ID NCT07370584
First seen Feb 02, 2026 · Last updated Apr 19, 2026 · Updated 18 times
Summary
This early-stage study aims to check if a new eye drop called IVMED-85 is safe for people to use. Thirty-six healthy adults will use the drops or a placebo in both eyes twice a day for six weeks. Researchers will carefully monitor participants for any side effects or changes in their vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY STUDY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Total Eye Care, P.A.
RECRUITINGMemphis, Tennessee, 38119, United States
Conditions
Explore the condition pages connected to this study.